AHG vs HSIC
Akso Health Group and Henry Schein, both Healthcare
Henry Schein is the larger company at $9.4B against $1.2B. Over the past year HSIC returned +24% against -23% for AHG.
| Figure | AHG | HSIC |
|---|---|---|
| Last close | $1.37 | $84.26 |
| Market cap | $1.2B | $9.4B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 24.6 |
| 1-year return | -23% | +24% |
| 5-year return | -24% | +7.4% |
| RyuScoresector-relative, 1–10 | n/a | 61/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Akso Health Group
Henry Schein
Revenue of $3.5B in Q2 2026, net income $94M. Its largest reported line is Global Distribution And Value Added Services, 69% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.